title: [Operative treatment of renal cell carcinoma].
abstract: Renal cell carcinoma represents the fifth most frequent malignant tumor in humans. At the time of diagnosis, 20% of the patients already manifest metastases. A further 20-30% of the patients develop systemic metastases in the postoperative course. Despite continued advances in pharmacological treatment options, cancer surgery tailored to the individual tumor findings constitutes the only curative treatment option.
authors.affiliation: Klinik und Poliklinik für Urologie, Universitätsklinikum Aachen, Pauwelsstrasse 30, Aachen, Germany. aheidenreich@ukaachen.de
authors.forename: A
authors.initials: A
authors.lastname: Heidenreich
mesh_terms: D002292:Carcinoma, Renal Cell / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D018450:Disease Progression; D018572:Disease-Free Survival; D006801:Humans; D007680:Kidney Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D008279:Magnetic Resonance Imaging; D009367:Neoplasm Staging; D009392:Nephrectomy / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D014057:Tomography, X-Ray Computed